Terms: = Skin cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Treatment
14 results:
1. Efficacy of Nivolumab and Ipilimumab Combined Therapy as a First-Line Therapy for Patients with Advanced Melanoma and the Urgent Need for an Effective Second-Line Therapy for Patients with Wild-Type BRAF in Japan: A Single Center Retrospective Study.
Muto I; Koga H; Doi R; Katayama E; Nakama K; Nakama T
Kurume Med J; 2023 Nov; 69(1.2):75-80. PubMed ID: 37793888
[TBL] [Abstract] [Full Text] [Related]
2. Biologically Interpretable Deep Learning To Predict Response to Immunotherapy In Advanced Melanoma Using Mutations and Copy Number Variations.
Zhang L; Cao L; Li S; Wang L; Song Y; Huang Y; Xu Z; He J; Wang M; Li K
J Immunother; 2023 Jul-Aug 01; 46(6):221-231. PubMed ID: 37220017
[TBL] [Abstract] [Full Text] [Related]
3. Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma skin cancer.
Clarke EL; Willenbrink TJ; Shelton M; Naeem A; Custer J; Lundgren AD; Boothe WD; Rathouz PJ; Adamson AS; Fox MC; Jambusaria-Pahlajani A
JAMA Dermatol; 2022 Aug; 158(8):919-922. PubMed ID: 35648411
[TBL] [Abstract] [Full Text] [Related]
4. Outcomes in surgical management of sinonasal malignancy-A single comprehensive cancer center experience.
Adilbay D; Valero C; Fitzgerald C; Yuan A; Mimica X; Gupta P; Wong RJ; Shah JP; Patel SG; Ganly I; Cohen MA
Head Neck; 2022 Apr; 44(4):933-942. PubMed ID: 35080076
[TBL] [Abstract] [Full Text] [Related]
5. DFSP of the Breast: Histomorphological, Immunohistochemical, and Molecular Features of a Rare Case in an Unusual Location.
Laharwani H; Prakash V; Walley D; Akhtar I
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):e73-e82. PubMed ID: 34282067
[TBL] [Abstract] [Full Text] [Related]
6. CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8
Braun M; Aguilera AR; Sundarrajan A; Corvino D; Stannard K; Krumeich S; Das I; Lima LG; Meza Guzman LG; Li K; Li R; Salim N; Jorge MV; Ham S; Kelly G; Vari F; Lepletier A; Raghavendra A; Pearson S; Madore J; Jacquelin S; Effern M; Quine B; Koufariotis LT; Casey M; Nakamura K; Seo EY; Hölzel M; Geyer M; Kristiansen G; Taheri T; Ahern E; Hughes BGM; Wilmott JS; Long GV; Scolyer RA; Batstone MD; Landsberg J; Dietrich D; Pop OT; Flatz L; Dougall WC; Veillette A; Nicholson SE; Möller A; Johnston RJ; Martinet L; Smyth MJ; Bald T
Immunity; 2020 Oct; 53(4):805-823.e15. PubMed ID: 33053330
[TBL] [Abstract] [Full Text] [Related]
7. Benefits of marriage on relative and conditional relative cancer survival differ between males and females in the USA.
Merrill RM; Johnson E
J Cancer Surviv; 2017 Oct; 11(5):578-589. PubMed ID: 28770444
[TBL] [Abstract] [Full Text] [Related]
8. Identification of melanoma biomarkers based on network modules by integrating the human signaling network with microarrays.
Huang C; Sheng Y; Jia J; Chen L
J Cancer Res Ther; 2014 Nov; 10 Suppl():C114-24. PubMed ID: 25450268
[TBL] [Abstract] [Full Text] [Related]
9. Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.
Larkin J; Del Vecchio M; Ascierto PA; Krajsova I; Schachter J; Neyns B; Espinosa E; Garbe C; Sileni VC; Gogas H; Miller WH; Mandalà M; Hospers GA; Arance A; Queirolo P; Hauschild A; Brown MP; Mitchell L; Veronese L; Blank CU
Lancet Oncol; 2014 Apr; 15(4):436-44. PubMed ID: 24582505
[TBL] [Abstract] [Full Text] [Related]
10. Outcomes for lymph node-positive cutaneous melanoma over two decades.
Martinez SR; Tseng WH; Young SE
World J Surg; 2011 Jul; 35(7):1567-72. PubMed ID: 21559997
[TBL] [Abstract] [Full Text] [Related]
11. Cosmetic results of histographically controlled excision of non-melanoma skin cancer in the head and neck region.
Eberle FC; Schippert W; Trilling B; Röcken M; Breuninger H
J Dtsch Dermatol Ges; 2005 Feb; 3(2):109-12. PubMed ID: 16351013
[TBL] [Abstract] [Full Text] [Related]
12. [Multivariate analysis of the prognostic factors in 230 surgically treated oral mucosal malignant melanomas].
Liu YS; Yang CH; Sun YF; Geng B; Yuan KF
Shanghai Kou Qiang Yi Xue; 2005 Oct; 14(5):466-71; discussion 471-2. PubMed ID: 16288323
[TBL] [Abstract] [Full Text] [Related]
13. Targeting of liposomes to melanoma cells with high levels of ICAM-1 expression through adhesive peptides from immunoglobulin domains.
Jaafari MR; Foldvari M
J Pharm Sci; 2002 Feb; 91(2):396-404. PubMed ID: 11835199
[TBL] [Abstract] [Full Text] [Related]
14. Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer.
Terwogt JM; Mandjes IA; Sindermann H; Beijnen JH; ten Bokkel Huinink WW
Br J Cancer; 1999 Mar; 79(7-8):1158-61. PubMed ID: 10098751
[TBL] [Abstract] [Full Text] [Related]
